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Abstract
Background: Myocardial edema is a substantial feature of the inflammatory response in human
myocarditis. The relation between myocardial edema and myocardial mass in the course of healing
myocarditis has not been systematically investigated. We hypothesised that the resolution of
myocardial edema as visualised by T2-weighted cardiovascular magnetic resonance (CMR) is
associated with a decrease of myocardial mass in steady state free precession (SSFP)-cine imaging.
Methods: 21 patients with acute myocarditis underwent CMR shortly after onset of symptoms
and 1 year later. For visualization of edema, a T2-weighted breath-hold black-blood triple-inversion
fast spin echo technique was applied and the ratio of signal intensity of myocardium/skeletal muscle
was assessed. Left ventricular (LV) mass, volumes and function were quantified from biplane cine
steady state free precession images.
11 healthy volunteers served as a control group for interstudy reproducibility of LV mass.
Results: In patients with myocarditis, a significant decrease in LV mass was observed during follow-
up compared to the acute phase (156.7 ± 30.6 g vs. 140.3 ± 28.3 g, p < 0.0001). The reduction of
LV mass paralleled the normalization of initially increased myocardial signal intensity on T2-
weighted images (2.4 ± 0.4 vs. 1.68 ± 0.3, p < 0.0001).
In controls, the interstudy difference of LV mass was lower than in patients (5.1 ± 2.9 g vs. 16.3 ±
14.2 g, p = 0.02) resulting in a lower coefficient of variability (2.1 vs 8.9%, p = 0.04).
Conclusion: Reversible abnormalities in T2-weighted CMR are paralleled by a transient increase
in left ventricular mass during the course of myocarditis. Myocardial edema may be a common
pathway explaining these findings.
Introduction
An array of reports demonstrated the linear correlation
between myocardial water content and T2-weighted cardi-
ovascular magnetic resonance (CMR) relaxation [1-7],
justifying its use as an in-vivo marker of myocardial
edema. Myocardial edema is a substantial feature of the
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inflammatory response in acute myocarditis[8,9]. Edema
is associated with diastolic dysfunction[10], conduction
disturbances[11], microvascular compression[12] and tis-
sue swelling[9]. The relation between myocardial edema
and myocardial mass over the course of myocarditis has
only rarely been systematically investigated in a clinical
setting [13,14]. This reflected the lack of a non-invasive
imaging modality allowing the in vivo, accurate and
simultaneous measurement of both parameters.
Indeed, histopathological quantification of edema is chal-
lenging. Over the last years, CMR has also become an
important tool for the non-invasive assessment of myo-
carditis [15-19]. On the other hand, steady state free pre-
cession (SSFP) CMR is the current gold standard to
measure myocardial mass[20] and detects even minor
changes during the course of diseases [21-25] or in
response to therapy. Sample size for studies of cardiac
remodeling can be reduced with the use of CMR[26].
Based on these considerations we attempted to explore
the relation between myocardial mass and T2-weighted
CMR-imaging in a group of myocarditis patients during
the acute and the convalescent phases of the disease.
We hypothesised that the resolution of myocardial edema
in the course of healing myocarditis as visualised by T2-
weighted CMR is associated with a measurable decrease in
myocardial mass in SSFP-cine CMR.
Methods
Patients and controls
A group of 21 patients with clinically suspected acute
myocarditis presenting to the emergency room was
included after CMR confirmed the diagnosis of acute
myocarditis. 16 of these patients have already been
described in a previous publication and were included ret-
rospectively[17]. 5 consecutive patients were included
prospectively. For inclusion, patients had to fulfill each of
the following clinical criteria:
- new onset of chest pain or shortness of breath
- history of acute infection within the last few weeks
- arrhythmias and/or pathological ECG findings
- elevation of cardiac serum markers (creatine kinase or
troponin T or I)
- exclusion of coronary artery disease by conventional cor-
onary angiography, except for patients <26 years with low
pre-test probability for coronary artery disease
Exclusion criteria were clinical evidence of chronic myo-
carditis (history, ECG changes suggestive of former myo-
carditis, previous positive CMR study, etc.), previous
myocardial infarction and contraindications for CMR
(automatic implantable defibrillators, pacemakers, intrac-
ranial aneurysm clip, etc.).
A control group of 11 healthy volunteers was scanned
twice in the course of 1 week to determine the interstudy
reproducibility of LV parameters in cine-SSFP imaging.
All participants gave informed written consent including
retrospective analysis of data and the study was approved
by the local ethics committee.
The acute CMR scan took place as soon as possible after
the patients' admission to our institution (2.6 ± 3.1 days,
mean ± SD). The follow-up scan was scheduled for 1 year
after, with some patients being referred for follow-up by
their physicians even earlier. At follow-up, patients were
asked to fill out questionnaires regarding heart failure
symptoms, cardiac arrhythmias and medical treatment.
CMR
All participants were examined using a 1.5 Tesla CMR
scanner (Signa CV/i, GE Healthcare Technologies, Mil-
waukee, WI, USA). Localization was performed using
breath-hold real time and steady-state free precession
images of true anatomical axes of the heart. Breath-hold
cine SSFP gradient echo images were acquired in a mid-
ventricular short axis, two- and four chamber view using a
four-element phased array cardiac coil. Field of view was
typically 380 × 380 mm, matrix size was 256 × 192 result-
ing in an in-plane resolution of 2 × 1.5 mm/pixel. Slice
thickness was 8 mm.
For assessment of edema a T2-weighted breath-hold
black-blood triple-inversion fast spin echo technique was
used (TR = 2RR, TE 64 ms, IT 140 ms, slice thickness 15
mm, matrix 256 × 256, field of view 34–38 cm) and
images were obtained in 3 short axis slices using the body
coil.
For assessment of the global relative enhancement (gRE)
a T1-weighted, ECG-triggered, free breathing spin echo
sequence in four identical axial slices both before and
after intravascular injection of 0.1 mmol gadolinium-
diethylenetriaminepentaacetate (Gd-DTPA, Magnevist,
Schering, Germany) was applied (TR 480 to 725 ms, TE 30
ms, slice thickness 6 mm, matrix size 256 × 256, body
coil). Measurements after Gd-DTPA were started immedi-
ately after injection (using an automated injector
[Medrad, Indianola, Pennsylvania]) and lasted 3 to 4 min.
(without any change in parameters in between).
After the acquisition of spin echo images, for acquisition
of late gadolinium enhancement (LGE) images, an addi-Journal of Cardiovascular Magnetic Resonance 2008, 10:19 http://www.jcmr-online.com/content/10/1/19
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tional dose (0.1 mmol) of Gd-DTPA was injected, and a
breathhold contrast-enhanced inversion-recovery gradi-
ent-echo sequence (TR 5.5 ms, TE 1.4 ms, TI 225 to 275
ms as individually optimized to null myocardial signal,
slice thickness/gap 15/5 mm, matrix 256 × 192) was
applied after a delay of 10 min in a stack of short axis
slices.
The diagnosis of acute myocarditis was obtained by com-
bining the clinical criteria described above with the CMR
findings. Acute myocarditis according to CMR was diag-
nosed when "any-two" of the three sequences described
above (T2-weighted sequences, gRE and LGE) was posi-
tive (as previously described by Abdel-Aty [17])
Coronary angiography
Conventional X-ray coronary angiography was performed
before the CMR examination by experienced cardiologists
on a standard angiography suite (Hicor, Siemens, Erlan-
gen, Germany).
Image analysis
For quantification of myocardial edema in T2-weighted
CMR, the ratio of mean signal intensity of the myocar-
dium compared to that of the skeletal muscle was used
(T2 ratio, as described elsewhere [18]). gRE was calculated
as previously described by Friedrich et al[18]. LGE was
analysed for the presence, number and transmurality of
areas of focal high signal intensity.
Left ventricular (LV) mass, volume and function was
measured in a biplanar area-length-method including
two- and four-chamber views (MASS 6, Medis, Leiden, the
Netherlands). LV endocardial and epicardial borders were
traced manually in both, papillary muscles were not
traced and thus excluded from LV mass measurement. LV
mass was calculated by multiplication of LV volumes by
the factor of 1.05 (specific gravity of the myocardium). LV
ejection fraction was calculated as EF = ([LVEDV-LVESV]/
LVEDV).
Image analysis was done by one investigator blinded to
the patients' clinical data.
Statistical analysis
The statistical tests were performed using a commercially
available statistical program (SPSS 11 for Macintosh, SPSS
GmbH Software, Munich, Germany). Continuous varia-
bles were compared using a paired student' t-test since all
of the variables were normally distributed as assessed by a
Kolmogorov-Smirnov test. Data were correlated using the
Spearman or Pearson correlation coefficients depending
on their distribution pattern. The coefficient of variability
(percentage) was calculated as the SD of the differences in
relation to the mean of the parameter under investigation.
Data are presented as mean ± standard deviation (SD). A
p-value of <0.05 was considered statistically significant.
Results
The group of patients with acute myocarditis consisted of
16 men and 5 women with a mean age of 36.4 ± 16.1
years (mean ± SD) presenting to the emergency room. Ini-
tially, 76% of the patients (16/21) received a beta blocker
and 95% an ACE-Inhibitor (20/21). Medication was con-
tinued in a substantial number of patients (beta blocker
43% [9/21], ACE-inhibitor 52% [11/21]) until after the
follow-up CMR scan. At follow-up, all patients were free
of symptoms and had no clinical evidence of ongoing
inflammation. Blood pressure values during both CMR
exams were within normal ranges (see table 1 for patients'
characteristics). In 16 patients (76%) the presence of sig-
nificant coronary artery disease (> 50% stenosis) was
excluded by conventional X-ray coronary angiography. 3
of these patients (14%) were younger than 26 years and
underwent this procedure because of their history of
smoking. 5 patients (24%) did not undergo this proce-
dure due to their age <26 years and a low pre-test proba-
bility of coronary artery disease (absence of cardiovascular
risk factors, age ranging from 16 to 26 years with a mean
age of 20.6 ± 3.6 years).
The control group consisted of 7 men and 4 female (age
31.6 ± 2.8 years, range 28–37 yrs.).
In patients, the LV mass in the presence of acute myocar-
ditis was not overt hypertrophic but still within normal
values at our institution. LV mass decreased significantly
from 156.7 ± 30.6 g in the acute phase to 140.3 ± 28.3 g
in the convalescent phase (p < 0.0001, see also figure 1
and 2). The average decrease of LV mass in the group of
patients was larger than the interstudy variability in bipla-
nar quantification of LV mass in our control group (16.3
± 13.9 g vs. 5.1 ± 2.9 g, p = 0.02, see table 2). The left ven-
tricular function (LV-EF) in cine imaging was within nor-
mal ranges in 18 patients (86%). However, LV-EF
improved slightly but significantly in most patients at fol-
low-up compared to the initial examination. The LV end-
diastolic volume (LVEDV) did not change during the fol-
low up period (quantitative results are given in table 3).
The observed reduction of LV mass in patients paralleled
the normalization of initially increased myocardial signal
intensity on T2-weighted images. However, no quantita-
tive correlation was found between reduction of myocar-
dial mass (10.2 ± 8.3%) and decrease of T2 ratio (28.5 ±
14.3%, p = 0.55) in the course of myocarditis.
11 patients (52%) had positive findings on LGE images at
presentation and at follow up. There were however no sig-
nificant differences in the severity of LGE findingsJournal of Cardiovascular Magnetic Resonance 2008, 10:19 http://www.jcmr-online.com/content/10/1/19
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(number or transmurality). Furthermore no correlation
was found between the presence of LGE and LV mass
reduction (p = 0.35) or LV mass at presentation (p = 0.86).
All of the patients had elevated cardiac serum markers
(creatine kinase or troponin T or I) at presentation. We
found no quantitative correlation between creatine kinase
(p = 0.80) or elevation of troponin (p = 0.45) and LV
mass.
Discussion
This study describes a reduction of LV mass in SSFP-cine
CMR during the course of healing myocarditis coming
along with a normalization of initially increased values in
T2-weighted CMR.
Hiramitsu et al[13] described 25 cases of biopsy proven
acute myocarditis with a transient thickening of both the
interventricular septum and left ventricular wall which
was associated with the presence of histologically con-
firmed interstitial edema. The ventricular wall thickening
as well as the edema resolved in the convalescent phase of
the disease. These results are also supported by several
echocardiographic reports describing a transient LV
hypertrophy during inflammation[14,27]. Following the
conclusions of Hiramitsu et al., we do think that the
observed decrease in LV mass in our study is comparable
to their data and most likely reflects the regression of
myocardial edema although we are not able to verify this
finding with histological data.
Schroeder et al. [28] assessed 51 patients with acute myo-
cardial infarction (AMI) and contemporary coronary
reperfusion therapy for global and regional myocardial
remodeling during the first year after AMI. They described
an increased LV mass one week after AMI with a signifi-
cant reduction in LV mass and LV wall thickness 6 months
after AMI which was strongly associated with the size of
infarction as assessed by peak creatine kinase-MB (CK-
MB). The authors ascribe their observation of increased LV
Table 1: Patients' characteristics
Nr Gender Age CAD 
excluded 
invasively
ECG Ck (U/l) Troponin (ug/l) BP 
(mmHg)
BP-FU 
(mmHg)
Initial 
medication
Medication 
at FU
1 Male 20 no ST-Elevation II, III, aVF, V3-5 
T-Inversion I, aVL
443 Troponin I 39.0 125/75 110/60 Metoprolol, 
Ramipril
Metoprolol, 
Ramipril
2 Male 36 yes ST-Elevation V5–V9 T-
Inversion III, aVF
407 Troponin I 8.5 138/74 146/92 Metoprolol, 
Ramipril
None
3 Male 50 yes ST-Elevation I, II, aVF, V5-6 609 Troponin I 70.0 105/70 n/a Metoprolol, 
Ramipril
None
4 Female 50 yes ST-Elevation V1, V2 T-
Inversion I, II, aVL, aVF, V2–V6
Troponin I 1.3 120/70 117/49 Ramipril Ramipril
5 Male 38 yes ST-Elevation II, III, aVF, V5-6 213 Troponin I 15.7 130/75 110/80 Ramipril None
6 Female 66 yes T-Inversion I, II, aVL, V2-6 547 Troponin T 1.8 118/73 122/70 Metoprolol, 
Ramipril
Metoprolol, 
Ramipril
7 Male 51 yes ST-Elevation V2-5 T-Inversion 
III
349 Troponin T 1.6 n/a 160/96 Metoprolol, 
Ramipril
Metoprolol
8 Female 24 yes AV-Block III 125 Troponin T 0.2 120/60 112/51 Metoprolol, 
Candesartan
None
9 Male 35 yes ST-Elevation I, II, aVF, V1-3, 
V5-6
166 Troponin T 0.22 120/75 n/a Ramipril Ramipril
10 Male 26 no ST-Elevation I, II, aVF, V4–V6 85 Troponin I 2.0 125/80 120/80 Metoprolol, 
Ramipril
Metoprolol, 
Ramipril
11 Male 37 yes ST-Elevation I, II, aVL, V4-6 1100 Troponin I 103.0 120/75 115/70 Metoprolol, 
Ramipril
Metoprolol, 
Ramipril
12 Female 63 yes ST-Elevation I, II, aVL, V5-6 T-
Inversion III
429 Troponin I 70.1 130/75 100/60 Metoprolol, 
Ramipril
Ramipril
13 Male 18 yes ST-Elevation II, III, aVF, V5-6 
T-Inversion II, III, aVF, V5-6
168 Troponin I 41.0 120/70 122/56 Metoprolol, 
Ramipril
None
14 Male 25 yes ST-Elevation II, III, aVF 1767 Troponin I 198.0 115/70 130/80 Metoprolol, 
Ramipril
Metoprolol
15 Male 40 yes ST-Elevation I, II, aVL, V5-6 T-
Inversion III
594 Troponin T 1.0 n/a n/a Metoprolol, 
Ramipril
None
16 Male 18 no initially Afib., later ST-
Elevation II, aVF, V3-6
148 Troponin I 0.4 120/70 120/70 Metoprolol, 
Ramipril
Metoprolol, 
Ramipril
17 Male 67 yes ST-Elevation II, III, aVF, V4-6 213 Troponin I 0.4 125/75 130/80 Metoprolol, 
Ramipril
None
18 Female 43 yes T-Inversion V1–V3 205 Troponin I 0.4 120/75 130/80 Metoprolol, 
Ramipril
Metoprolol, 
Ramipril
19 Male 18 yes ST-Elevation I, II 52 Troponin I 0.4 120/70 125/95 Metoprolol, 
Ramipril, 
Torasemid
Metoprolol, 
Ramipril
20 Male 16 no ST-Elevation II, III, aVF 82 Troponin I 0.3 120/70 130/80 Ramipril Ramipril
21 Male 23 no ST-Elevation I, II, aVF, V2-5 T-
Inversion III
570 Troponin I 0.3 120/60 124/72 None None
Patients' clinical data at admission (Ck: creatine kinase, CAD: coronary artery disease, BP: blood pressure, FU: follow-up)Journal of Cardiovascular Magnetic Resonance 2008, 10:19 http://www.jcmr-online.com/content/10/1/19
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mass shortly after AMI to myocardial edema, because
experimental studies have shown early interstitial edema
of infarcted myocardium and increased LV mass [29] and
animal studies by magnetic resonance imaging confirm
these findings[1,2,4]. The article of Schroeder et al. sup-
ports the theory that myocardial edema leads to a measur-
able increase in LV mass in CMR.
The reduction of LV mass described in this report may in
theory be a result of medical therapy rather than regres-
sion of edema. Due to the long time interval between the
two CMR examinations, the observed reduction of LV
mass might be an effect of medication with ACE-Inhibi-
tors or β-blockers which were received by most patients.
However, the initial LV mass was not hypertrophic but in
the upper range of the normal values and none of the
patients was hypertensive. Furthermore, the dosage of
ramipril and metoprolol was rather low compared to the
usual dosages described for regression of LV hypertrophy
[30-32]. Since to our knowledge no decremental effect of
therapy with ACE-Inhibitors or β-blockers on LV mass in
non-hypertrophic non-hypertonic hearts is reported, we
CMR images in the acute (left) and convalescent (right) phase of myocarditis Figure 1
CMR images in the acute (left) and convalescent (right) phase of myocarditis. Upper left: SSFP-cine images showing increased 
LV mass compared to follow-up (upper right). Lower left: T2-weighted STIR images with higher signal intensity of myocardium 
compared to follow-up (lower right). [SSFP: steady-state free precession].
LV mass in cine-CMR in the acute and convalescent phase  (follow-up) of myocarditis (dotted line: mean values of LV  mass) Figure 2
LV mass in cine-CMR in the acute and convalescent phase 
(follow-up) of myocarditis (dotted line: mean values of LV 
mass).Journal of Cardiovascular Magnetic Resonance 2008, 10:19 http://www.jcmr-online.com/content/10/1/19
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tend to believe that the reduction of LV mass in our study
comes secondary to regressive edema.
In our study, the reduction of LV mass was strongly asso-
ciated with a decrease of signal intensity on T2-weighted
images (T2-ratio), although we were not able to find a
quantitative correlation of both parameters. Higgins et al.
as well as many other authors [1-5] describe a linear cor-
relation between myocardial water content and T2-
weighted cardiovascular magnetic resonance (CMR) relax-
ation. They found that despite the linear correlation, small
changes of myocardial water content result in large T2-
changes which may explain the relatively low difference of
LV mass compared with larger changes in T2-ratio in the
present study. The inversion recovery sequence we used is
in fact not purely T2-weighted but is sensitive to tissues
with long T1-relaxation times as well. This may have acted
to 'amplify' the effect of free water – known to have long
T1 and long T2 weighted relaxation times-resulting in a
water-weighted image.
Limitations
Left ventricular mass was not analyzed in contiguous
short axis stacks that are considered the gold standard.
Nevertheless we used 2D measurements for pairwise
intraindividual comparisons both in patients and in con-
trols. Previous studies found differences in LV mass
between 2D and 3D measurements to be small[33]. In
these studies, 2D quantification underestimated LV mass
compared to 3D methods, thereby the true effect of tissue
swelling might even be larger than reported.
We are well aware that the lack of endomyocardial biop-
sies is a certain limitation to our study. To ascertain the
diagnosis of acute myocarditis we preferred a clinical
approach. This is due to two reasons: First, the sensitivity
of endomyocardial biopsy to diagnose myocarditis is lim-
ited and remains a controversial issue[34]. Second, our
cohort of patients was rather young, presenting acutely
with typical signs suggestive of myocarditis although none
of them was severly ill in terms of heart failure. All
patients revealed a preserved ejection fraction, there was
no clinical need for endomyocardial biopsy. Although the
theoretical possibility exists that some of our patients suf-
fered from coronary artery disease, the invasive exclusion
of coronary stenosis in patients with a low pretest proba-
bility makes this rather unlikely.
The small sample size of our study requires further evalu-
ation of the hypothesis with larger studies and the fact
that this is not a prospective study weakens the methodo-
logical quality of our work.
The possible effect of medication on our findings cannot
be fully ascertained since the control group was not sub-
jected to the same medical treatment.
Conclusion
A transient elevation of global myocardial T2 signal inten-
sity is associated with a transient increase in left ventricu-
lar mass. Myocardial edema in the acute phase resolving
at follow up could provide a potential explanation of our
Table 2: Results of repeated cine-CMR
Variable 1st examination 2nd examination Difference between means P-value 1st vs. 2nd examination
LV mass (g) 140.90 ± 31.50 139.64 ± 31.00 1.30 0.50
LV mass/height (g/cm) 0.77 ± 0.15 0.78 ± 0.13 0.01 0.34
LVEDV (ml) 176.49 ± 29.13 174.36 ± 31.11 2.09 0.43
LVEDV/height (ml/cm) 0.97 ± 0.16 0.96 ± 0.15 0.01 0.34
Ejection fraction (%) 61.36 ± 3.70 61.73 ± 3.41 0.36 0.60
T2 ratio 1.70 ± 0.20 1.64 ± 0.21 0.06 0.65
Quantitative results of repeated cine-CMR in volunteers (mean ± SD): LV mass, LV mass/height, LVEDV, LVEDV/height, ejection fraction, T2 ratio
Table 3: CMR results in acute myocarditis and at follw-up
Variable Acute Follow-up Difference between means P-value acute vs. follow-up
LV mass (g) 156.66 ± 30.56 140.33 ± 28.30 -16.33 <0.0001
LV mass/height (g/cm) 0.90 ± 0.15 0.80 ± 0.12 -0.10 0.0001
LVEDV (ml) 158.10 ± 40.01 153.57 ± 37.50 -4.52 0.395
LVEDV/height (ml/cm) 0.89 ± 0.19 0.85 ± 0.19 -0.04 0.2859
Ejection fraction (%) 59.95 ± 6.39 64.14 ± 5.26 4.19 0.015
T2 ratio 2.41 ± 0.39 1.68 ± 0.29 -0.72 <0.0001
Quantitative results of CMR in the acute and convalescent phase (follow-up) of myocarditis (mean ± SD): LV mass, LV mass/height, LVEDV, LVEDV/
height, ejection fraction, T2 ratioJournal of Cardiovascular Magnetic Resonance 2008, 10:19 http://www.jcmr-online.com/content/10/1/19
Page 7 of 8
(page number not for citation purposes)
findings although other factors may contribute to this
relation.
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